Lung Diseases, Obstructive: all 2,584 studies

Page 4 of 26. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• Adherence Study in COPD PatientsCompletedNCT02864342Phase 4Results posted
• Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02850978Results posted
• The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary DiseaseCompletedNCT02845752Phase 4Results posted
• HFNC Effect on BCSS in Patients With COPDTerminatedNCT02825043Not applicableResults posted
• Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsCompletedNCT02814656Phase 1Results posted
• AMPLIFY - D6571C00001 Duaklir USA Phase III StudyCompletedNCT02796677Phase 3Results posted
• Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)CompletedNCT02796651Phase 2Results posted
• Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary PathologyCompletedNCT02787863Phase 4Results posted
• Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02786927Phase 4Results posted
• Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary DiseaseCompletedNCT02774226Phase 2Results posted
• Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02729051Phase 3Results posted
• Stage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyTerminatedNCT02722304Phase 3Results posted
• The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD PatientsTerminatedNCT02707770Not applicableResults posted
• Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary DiseaseCompletedNCT02700919Phase 2Results posted
• Airway Effects of Tiotropium in Patients With COPDCompletedNCT02683668Phase 3Results posted
• The Use of High Frequency Oscillations With NIV in Hypercapnic COPD ParticipantsTerminatedNCT02680639Not applicableResults posted
• Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical PracticeCompletedNCT02675517Results posted
• A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT02662582Phase 2Results posted
• A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male SubjectsCompletedNCT02648438Phase 1Results posted
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese MenCompletedNCT02645253Phase 1Results posted
• QVA Mechanistic Efficacy Study (Receptor Effects, Etc)CompletedNCT02634983Phase 4Results posted
• A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary DiseaseTerminatedNCT02628769Phase 2Results posted
• Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPDCompletedNCT02603393Phase 4Results posted
• Home-Based Health Management of COPD PatientsCompletedNCT02557178Not applicableResults posted
• Nasal High Flow Therapy 30 Day Readmission StudyTerminatedNCT02552732Not applicableResults posted
• Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02551224Not applicableResults posted
• Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT02536508Phase 3Results posted
• Phase IV O2 Consumption Study in COPD Patients.CompletedNCT02533505Phase 4Results posted
• A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute ExacerbationCompletedNCT02522299Phase 2Results posted
• A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02518139Phase 3Results posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02512510Phase 3Results posted
• Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT02512302Phase 1Results posted
• Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT02487498Phase 3Results posted
• Efficacy and Safety Study of QVA149 in COPD PatientsCompletedNCT02487446Phase 3Results posted
• Walk On! Physical Activity CoachingCompletedNCT02478359Not applicableResults posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02459080Phase 3Results posted
• A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251CompletedNCT02449018Phase 2Results posted
• Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT02447575Not applicableResults posted
• Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD PatientsCompletedNCT02442206Phase 4Results posted
• Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of ExacerbationsCompletedNCT02418468Phase 4Results posted
• A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPDCompletedNCT02371629Phase 4Results posted
• An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary DiseaseTerminatedNCT02366637Phase 2Results posted
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)CompletedNCT02347774Phase 3Results posted
• A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02345161Phase 3Results posted
• Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPDCompletedNCT02343458Phase 3Results posted
• Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD PatientsCompletedNCT02331940Not applicableResults posted
• Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary SyndromesCompletedNCT02324660Not applicableResults posted
• Juno Perth Clinical TrialTerminatedNCT02317042Not applicableResults posted
• Targeted Retreatment of COPD ExacerbationsCompletedNCT02300220Phase 3Results posted
• Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02299375Phase 2Results posted
• Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.CompletedNCT02296138Phase 3Results posted
• An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedNCT02294734Phase 2Results posted
• Pre/Post Pilot Test of Video Module EducationCompletedNCT02278237Not applicableResults posted
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPDCompletedNCT02276222Phase 3Results posted
• A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsTerminatedNCT02275481Phase 4Results posted
• A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD PatientsCompletedNCT02272634Phase 2Results posted
• Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) StudyCompletedNCT02261727Phase 4Results posted
• A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02257372Phase 4Results posted
• The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary DiseaseCompletedNCT02252588Phase 2Results posted
• Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSACompletedNCT02244957Not applicableResults posted
• Pulmonary Embolism as a Cause of COPD ExacerbationsCompletedNCT02238639Not applicableResults posted
• A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance TherapyCompletedNCT02238483Phase 2Results posted
• A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02236611Phase 4Results posted
• Aides in Respiration Health Coaching for COPDCompletedNCT02234284Not applicableResults posted
• A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02233543Phase 4Results posted
• Social Work Intervention Focused on TransitionsCompletedNCT02232126Not applicableResults posted
• Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02231177Phase 1Results posted
• A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT02207829Phase 3Results posted
• Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)CompletedNCT02202616Phase 4Results posted
• Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02196077Phase 2Results posted
• A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)CompletedNCT02184611Phase 3Results posted
• Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to TyvasoTerminatedNCT02178566Phase 2Results posted
• Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPDCompletedNCT02165826Phase 3Results posted
• A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02164513Phase 3Results posted
• Asthma Data Innovation Demonstration ProjectCompletedNCT02162576Not applicableResults posted
• Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary DiseaseCompletedNCT02157935Phase 3Results posted
• Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCompletedNCT02155660Phase 3Results posted
• A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02153489Phase 4Results posted
• Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCompletedNCT02138916Phase 3Results posted
• TOPIC Trial for COPDCompletedNCT02135432Early Phase 1Results posted
• Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD PatientsCompletedNCT02125734Phase 4Results posted
• Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2CompletedNCT02119286Phase 3Results posted
• PATient Navigator to rEduce ReadmissionsCompletedNCT02114515Not applicableResults posted
• A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02109172Phase 2Results posted
• Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02105974Phase 3Results posted
• Comparative Effectiveness of a Peer-led O2 Infoline for Patients and CaregiversCompletedNCT02098369Phase 4Results posted
• Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary EventsCompletedNCT02096731Results posted
• Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02077465Phase 1Results posted
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.CompletedNCT02075541Phase 2Results posted
• Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPDCompletedNCT02059434Phase 1Results posted
• Specialized Community Disease Management to Reduce Substance Use and Hospital ReadmissionsCompletedNCT02059005Not applicableResults posted
• Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPDCompletedNCT02055352Phase 4Results posted
• A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02040792Phase 2Results posted
• Improving Patient-Centered Care Delivery Among Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02036294Not applicableResults posted
• Integrating Care After Exacerbation of COPDCompletedNCT02021955Not applicableResults posted
• A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02014480Phase 3Results posted
• Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)CompletedNCT02006732Phase 3Results posted
• Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.CompletedNCT01996319Phase 3Results posted
• A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01978145Phase 3Results posted
• Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)CompletedNCT01970878Phase 3Results posted

← Lung Diseases, Obstructive overview